Bradley Foster & Sargent Inc Axogen, Inc. Transaction History
Bradley Foster & Sargent Inc
- $5.82 Billion
- Q3 2024
A detailed history of Bradley Foster & Sargent Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 81,164 shares of AXGN stock, worth $1.34 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
81,164Holding current value
$1.34 Million% of portfolio
0.02%Shares
7 transactions
Others Institutions Holding AXGN
# of Institutions
162Shares Held
36.6MCall Options Held
230KPut Options Held
400-
First Light Asset Management, LLC Edina, MN4.09MShares$67.4 Million5.0% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$53.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$49.6 Million3.58% of portfolio
-
Morgan Stanley New York, NY2.9MShares$47.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$40 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $697M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...